RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+4%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$7.22B
AUM Growth
+$7.22B
Cap. Flow
+$1.06B
Cap. Flow %
14.76%
Top 10 Hldgs %
44.55%
Holding
109
New
17
Increased
10
Reduced
8
Closed
14

Top Buys

1
CLYM
Climb Bio, Inc. Common Stock
CLYM
$236M
2
IVVD icon
Invivyd
IVVD
$226M
3
CTKB icon
Cytek Biosciences
CTKB
$206M
4
ICVX
Icosavax, Inc. Common Stock
ICVX
$171M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$171M

Top Sells

1
AXSM icon
Axsome Therapeutics
AXSM
$112M
2
NVAX icon
Novavax
NVAX
$95.8M
3
CRIS icon
Curis
CRIS
$57.6M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$56.4M
5
CCXI
ChemoCentryx, Inc.
CCXI
$56.1M

Sector Composition

1 Healthcare 99.06%
2 Financials 0.62%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRDS
76
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.95M 0.14%
1,000,000
– –
CNCE
77
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$9.92M 0.14%
3,033,603
– –
ARYE
78
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$9.88M 0.14%
+1,000,000
New +$9.88M
FLACU
79
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$9.82M 0.14%
1,000,000
– –
IMA
80
ImageneBio, Inc. Common Stock
IMA
$153M
$9.47M 0.13%
750,000
– –
PHAS
81
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$8.86M 0.12%
2,850,000
– –
HLTH
82
DELISTED
Cue Health Inc. Common Stock
HLTH
$8.86M 0.12%
+750,000
New +$8.86M
COGT icon
83
Cogent Biosciences
COGT
$1.83B
$8.63M 0.12%
1,025,641
– –
CGEM icon
84
Cullinan Oncology
CGEM
$456M
$7.9M 0.11%
350,000
– –
OCUL icon
85
Ocular Therapeutix
OCUL
$2.25B
$7.5M 0.1%
750,000
– –
FVAM
86
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$7.37M 0.1%
750,000
– –
MLTX icon
87
MoonLake Immunotherapeutics
MLTX
$3.78B
$6.97M 0.1%
700,000
– –
OBIO icon
88
Orchestra BioMed
OBIO
$147M
$6.18M 0.09%
625,000
– –
BMEA icon
89
Biomea Fusion
BMEA
$114M
$5.99M 0.08%
500,000
– –
CVRX icon
90
CVRx
CVRX
$204M
$4.55M 0.06%
275,000
– –
SYRS
91
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4.02M 0.06%
900,000
– –
CCXI
92
DELISTED
ChemoCentryx, Inc.
CCXI
$3.74M 0.05%
218,532
-3,278,107
-94% -$56.1M
OTIC
93
DELISTED
Otonomy, Inc.
OTIC
$3.13M 0.04%
+1,631,635
New +$3.13M
OKUR
94
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$464K 0.01%
62,217
– –
VRDN icon
95
Viridian Therapeutics
VRDN
$1.59B
$17K ﹤0.01%
1,034
-311,294
-100% -$5.12M
CEREW
96
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
– –
-233,333
Closed -$3.36M
TRIL
97
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-5,290,481
Closed -$51.3M
ARYD
98
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
– –
-1,000,000
Closed -$10.7M
CERE
99
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-2,200,000
Closed -$56.4M
TXMD icon
100
TherapeuticsMD
TXMD
$12.7M
– –
-7,812,500
Closed -$9.3M
1 2 3
4
5